The company’s ultra-sensitive biomarker technology supports milestone achievement in establishing a method for clinicians to identify and interpret elevated values of sNfL in children...
Octave Bioscience, announced the closing of a $30M extension to its Series B funding round. The round included participation from new strategic investors: Novartis (dRx...
Artificial intelligence (AI) can use data from low-dose CT scans of the lungs to improve risk prediction for death from lung cancer, cardiovascular disease...
VitalConnect, Inc., a leader in remote and in-hospital wearable biosensor technology, announced closing on an oversubscribed Series F financing in excess of $30 million....
Illumina Inc., a global leader in DNA sequencing and array-based technologies, announced the launch of the latest version of DRAGEN™ software for analysis of...
